AUPP263498A0 - Novel therapeutic molecules and uses therefor - Google Patents
Novel therapeutic molecules and uses thereforInfo
- Publication number
- AUPP263498A0 AUPP263498A0 AUPP2634A AUPP263498A AUPP263498A0 AU PP263498 A0 AUPP263498 A0 AU PP263498A0 AU PP2634 A AUPP2634 A AU PP2634A AU PP263498 A AUPP263498 A AU PP263498A AU PP263498 A0 AUPP263498 A0 AU PP263498A0
- Authority
- AU
- Australia
- Prior art keywords
- novel therapeutic
- therapeutic molecules
- uses therefor
- therefor
- molecules
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000001225 therapeutic effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4716—Muscle proteins, e.g. myosin, actin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/07—Animals genetically altered by homologous recombination
- A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Microbiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP2634A AUPP263498A0 (en) | 1998-03-27 | 1998-03-27 | Novel therapeutic molecules and uses therefor |
EP99912974A EP1064374A1 (en) | 1998-03-27 | 1999-03-26 | Novel molecules expressed during muscle development and genetic sequences encoding the same |
AU31277/99A AU3127799A (en) | 1998-03-27 | 1999-03-26 | Novel molecules expressed during muscle development and genetic sequences encoding the same |
PCT/AU1999/000220 WO1999050410A1 (en) | 1998-03-27 | 1999-03-26 | Novel molecules expressed during muscle development and genetic sequences encoding the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPP2634A AUPP263498A0 (en) | 1998-03-27 | 1998-03-27 | Novel therapeutic molecules and uses therefor |
Publications (1)
Publication Number | Publication Date |
---|---|
AUPP263498A0 true AUPP263498A0 (en) | 1998-04-23 |
Family
ID=3806895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AUPP2634A Abandoned AUPP263498A0 (en) | 1998-03-27 | 1998-03-27 | Novel therapeutic molecules and uses therefor |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1064374A1 (en) |
AU (1) | AUPP263498A0 (en) |
WO (1) | WO1999050410A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2003534809A (en) * | 2000-05-30 | 2003-11-25 | メディジェーン アクチェンゲゼルシャフト | Novel target genes for heart disease |
AU2001268570A1 (en) * | 2000-06-16 | 2001-12-24 | Millennium Pharmaceuticals, Inc. | 33358, a novel human ankyrin family member and uses thereof |
US7629308B2 (en) | 2000-07-07 | 2009-12-08 | Board Of Regents, The University Of Texas System | Methods relating to muscle selective calcineurin interacting protein (MCIP) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU577259B2 (en) * | 1982-08-13 | 1988-09-22 | Zymogenetics Inc. | Glycolytic promters for regulated protein expression protease inhibitor |
US4876197A (en) * | 1983-02-22 | 1989-10-24 | Chiron Corporation | Eukaryotic regulatable transcription |
US4880734A (en) * | 1984-05-11 | 1989-11-14 | Chiron Corporation | Eukaryotic regulatable transcription |
CA2005600A1 (en) * | 1988-12-20 | 1990-06-20 | Cal-Henrik Heldin | Endothelial cell growth factor |
WO1995020975A1 (en) * | 1994-02-04 | 1995-08-10 | The Regents Of The University Of California | Tef-1 isoforms and uses thereof |
-
1998
- 1998-03-27 AU AUPP2634A patent/AUPP263498A0/en not_active Abandoned
-
1999
- 1999-03-26 EP EP99912974A patent/EP1064374A1/en not_active Withdrawn
- 1999-03-26 WO PCT/AU1999/000220 patent/WO1999050410A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1064374A1 (en) | 2001-01-03 |
WO1999050410A1 (en) | 1999-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2113599A (en) | Human protease molecules | |
EP1015578A4 (en) | Therapeutic molecules | |
AU9403798A (en) | Human regulatory molecules | |
AU1184399A (en) | Therapeutic molecules | |
EP1147213A4 (en) | Novel rgs-containing molecules and uses thereof | |
AU5320700A (en) | Novel toll molecules and uses therefor | |
AU2587399A (en) | Human transport-associated molecules | |
AU4629399A (en) | Substituted piperazones and their therapeutic uses | |
AUPP263498A0 (en) | Novel therapeutic molecules and uses therefor | |
AUPM885894A0 (en) | Therapeutic molecules | |
AUPQ884500A0 (en) | Novel therapeutic molecules and uses therefor - III | |
AU2591099A (en) | Human proteinase molecules | |
AUPP551298A0 (en) | Novel therapeutic molecules and uses therefor | |
AU5611799A (en) | Novel therapeutic molecules and uses therefor | |
AUPP625298A0 (en) | Novel therapeutic molecules and uses therefor - II | |
AUPP798698A0 (en) | Novel therapeutic molecules and methods relating thereto | |
AU5005099A (en) | Benzoquinolizidine and benzoindolizidine derivatives and therapeutic uses thereof | |
AUPQ150499A0 (en) | Novel therapeutic molecules and uses thereof-II | |
AUPP573398A0 (en) | Therapeutic molecules and methods | |
AUPQ033999A0 (en) | Novel therapeutic molecules and uses thereof | |
AUPQ158499A0 (en) | Therapeutic molecules and methods-ii | |
AUPQ157499A0 (en) | Therapeutic molecules and methods-iii | |
AUPO926397A0 (en) | Novel therapeutic molecules | |
AUPP096197A0 (en) | Novel molecules and uses thereof-iv | |
AUPO896397A0 (en) | Novel molecules and uses thereof-iii |